Only Available By Prescription
Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Foundayo (orforglipron) is a once-daily prescription pill indicated for long-term weight management in adults. It is prescribed alongside a calorie-reduced diet and regular physical activity for patients who are obese, or for those who are overweight and carry an additional weight-related condition such as elevated blood pressure, elevated cholesterol, or type 2 diabetes.
Orforglipron is classified as a GLP-1 receptor agonist, a type of medication that acts on the same receptors as a hormone your body naturally produces after eating. By activating these receptors, Foundayo helps curb appetite, promotes satiety, and slows digestion, supporting patients in reducing their overall calorie intake and sustaining weight loss over the long term.
Foundayo is a small-molecule oral tablet, which means it does not require fasting, special timing, or water restrictions before or after taking it. It can be taken once daily at any hour, with or without a meal.
| Fact Table | |
| Formula | C48H48F2N10O5 |
| License | US FDA (approved 2026) |
| Bioavailability | 77% absolute oral bioavailability (0.8 mg dose); no clinically relevant food effect |
| Legal status | Prescription only (Rx-only, U.S.) |
| Chemical Name | Orforglipron (LY-3502970) |
| Elimination half-life | 29–49 hours |
| Dosage (Strength) | 0.8 mg, 2.5 mg, 5.5 mg, 9 mg, 14.5 mg, and 17.2 mg oral tablets; start 0.8 mg once daily, titrate at ≥30-day intervals; max 17.2 mg once daily |
| Pregnancy | Weight loss offers no benefit in pregnancy and may cause fetal harm; discontinue when pregnancy is recognized |
| Brands | Foundayo |
| Protein binding | >99% |
| PubChem CID | 137319706 |
| MedlinePlus | Not available |
| ChEBI | Not available |
| ATC code | None assigned |
| DrugBank | DB18964 |
| KEGG | D12536 |
| Routes of administration | Oral |
Foundayo treatment begins at a starting dose of 0.8 mg once daily by mouth. To allow the body to adjust and minimize gastrointestinal discomfort, the dose is stepped up gradually, with increases no sooner than every 30 days, up to a maximum dose of 17.2 mg once daily, depending on how well the medication is tolerated and how the patient responds.
Tablets must be swallowed whole and should not be split, crushed, or chewed. There are no food or fluid requirements associated with taking Foundayo, it may be taken at any point during the day, regardless of meals.
If a dose is skipped, take it when remembered, provided you do not take two doses within the same calendar day. Should treatment be paused for a week or more, speak with your prescriber before resuming.
The active ingredient in Foundayo is orforglipron.
The tablet also contains the following inactive ingredients: copovidone, crospovidone, magnesium stearate, microcrystalline cellulose, and anhydrous sodium carbonate. The film coat is composed of polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.
Foundayo is contraindicated in patients who have a personal or family history of medullary thyroid carcinoma (MTC) or a diagnosis of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
This medication should not be taken by anyone with a known allergy or serious hypersensitivity reaction to orforglipron or to any component of the formulation.
Before starting treatment, advise your doctor of any history of pancreatitis, kidney disease, significant liver impairment, delayed gastric emptying (gastroparesis), or diabetic retinopathy.
Patients using oral contraceptives should be aware that Foundayo may decrease their effectiveness. An additional or alternative form of birth control may be advised during the first 30 days of treatment and for 30 days following each dose escalation.
Use during pregnancy is not advised, and breastfeeding while on this medication is not recommended. Always give your healthcare provider a full picture of your health history, current medications, and any known allergies before beginning Foundayo.
Commonly reported side effects with Foundayo use include nausea, stomach pain or cramping, acid reflux, constipation, loose stools, gas, bloating, vomiting, indigestion, burping, headache, tiredness, and temporary hair thinning.
More serious reactions that have been associated with this medication include pancreatitis, gallbladder complications, kidney injury, hypoglycemia when combined with other glucose-lowering agents, severe hypersensitivity reactions, and visual disturbances in patients managing type 2 diabetes.
If you develop severe or prolonged abdominal pain, any signs of a serious allergic reaction, or any other symptoms that feel unusual or persistent, discontinue use and seek medical attention promptly. The above does not represent a comprehensive list of every potential side effect.
Exceptional Customer Service
We pride ourselves on delivering excellent customer service with as much accessibility as possible.
If you have any questions at all, or would like to place an order, you are encouraged to contact us by toll-free
phone 1-888-904-8467 or email info@canadadrugsdirect.com.
Top Safety and Quality
Canada Drugs Direct employs dedicated, professional licensed pharmacists to ensure that each and every order is reviewed before it is dispensed for the safety and health of our customers. At CanadaDrugsDirect.com, your health is our top priority.
Product Reviews